ByTrending Posts
Bristol Myers Squibb Taps AI-Driven Discovery with Terray…
Los Angeles – Dec 14, 2023 Terray Therapeutics, a leader in AI-driven small molecule discovery, has entered into…
PostEra and Amgen Forge AI Drug Discovery Partnership…
Boston – Nov 16, 2023 Advancing Small Molecule Therapeutics with AI PostEra has entered into a multi-target research…
NVIDIA Backs Terray Therapeutics to Advance Generative AI…
Los Angeles – Nov 9, 2023 Terray Therapeutics, a biotechnology company pioneering AI-driven small molecule discovery, has secured…
Merck (HQ Germany) Strengthens AI-Driven Drug Discovery with…
Darmstadt, Germany – Sept 20, 2023 Advancing AI-Powered Drug Development in Oncology, Neurology, and Immunology Merck, a global…
BenevolentAI Announces Strategic Collaboration with Merck, Darmstadt, Germany
London, UK – Sept 20, 2023 Partnership Utilizes AI-Driven Drug Discovery to Advance Oncology, Neurology, and Immunology Treatments…
XtalPi and Eli Lilly Partner in $250M AI-Driven…
Cambridge, MA – June 1 2023 XtalPi Inc., a pioneering AI-powered pharmaceutical technology company, has announced a strategic…
XtalPi and Janssen Partner to Accelerate AI-Driven Small…
Shenzhen, China – Oct 27 2022 XtalPi Inc., a leading AI-powered pharmaceutical technology company, announced a strategic research…
GSK Expands AI Capabilities with $70 Million Tempus…
London, UK – October 18, 2022 GSK has entered into a $70 million agreement with Tempus, a leader…
Eli Lilly and Genesis AI Announce $670M AI-Driven…
BURLINGAME, California – May 3, 2022 Harnessing AI to Unlock Breakthrough Therapies Eli Lilly and Company and Genesis…
Trending Posts
Latest Stories
Did AbbVie Successfully Manage 2025 Headwinds, and Are Rinvoq and Skyrizi Poised to Reach $31B+ Sales by 2027?
NORTH CHICAGO, ILLINOIS — As 2025 comes to a close, AbbVie reflects on a year…
Is Lilly Shaping Its Post-Blockbuster Future Through Verve, Superluminal, and AI-Driven Partnerships in 2025?
In 2025, Eli Lilly and Company approached dealmaking from a position of strength. With blockbuster…
Is Lilly Strengthening Its 2026 Growth Outlook by Scaling Zepbound, Mounjaro, and Its Core Innovation Engine in 2025?
In 2025, Eli Lilly and Company continued to build on its strong momentum, executing a…
Pfizer’s Strategic Deals in 2025: Key Moves Shaping the Company’s Next Phase
Strategic Takeaways In 2025, Pfizer executed a series of focused and strategic deals aimed at…
Gallery
